ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,780, issued on Aug. 12, was assigned to XinThera Inc. (Foster City, Calif.).
"PARP1 inhibitors and uses thereof" was invented by Qing Dong (San Diego), Robert L. Hoffman (San Diego), Stephen W. Kaldor (Foster City, Calif.), Joseph Robert Pinchman (San Diego), Lynnie Trzoss (San Diego) and Porino Jinjo Va (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer."
The patent was filed on July 18, 2024, under Application No. 18/777,202.
*For further information, including imag...